Enabling homes to realise zero pollution holds multiple health benefits for all Europeans – especially our children. This is the goal of the EU-funded INQUIRE project. It will provide the knowledge, tools and measures needed to significantly enhance indoor air quality. Research on hazardous determinants and their sources, risk factors and effects will focus in particular on infants and young children up to 5 years old. The work will include non-invasive sampling and monitoring of over 200 homes in eight countries over the course of 1 month. Results will inform evidence-based recommendations and support beneficial exploitation by industry and policymakers.
Welcome to the 2025 online INQUIRE consortium meeting
The first IDEAL Cluster policy brief is out – check it out!
Are you interested in air quality research?
Join our workshop and learn how we use real-life air pollutants for in vitro toxicological assessment!
Statement📢 The #LEARNproject consortium has decided to leave the X platform and fully focus its efforts on LinkedIn, which provides a more enriching environment for science dissemination and bigger opportunities for stakeholder engagement. Follow us on
🎬 The #LEARNproject is carrying out cohorts at European #schools to analyse exposure to #airpollutants, their effects on children's health and cognition, and the impact of #filtration technologies.
Discover how they work in our new video below!
📢 Adrià Sunyer Caldú recently presented new results from the @INQUIRE_EU project entitled, "Chemical Profiling and #toxicity of the Airborne Exposome in Indoor and Outdoor Environments using #PDMS Foam Passive Samplers" at the #SETAC Europe in Vienna, Austria 😃
2This work was co-funded by UK Research and Innovation (UKRI) under the UK government’s Horizon Europe funding guarantee [grant number 10038689 and 10042425].
Co-funded by the European Union. Views and opinions expressed are however those of the author(s) only and do not necessarily reflect those of the European Health and Digital Executive Agency (HaDEA). Neither the European Union nor the granting authority can be held responsible for them.
The work received funding support from the Australian National Health and Medical Research Council (NHMRC) [NHMRC; 2022/GNT2017837].